Literature DB >> 20501684

Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people.

Zhen Yang1, Zhaoyun Zhang, Jie Wen, Xuanchun Wang, Bin Lu, Zhihong Yang, Weiwei Zhang, Mei Wang, Xiaocheng Feng, Charlotte Ling, Songhua Wu, Renming Hu.   

Abstract

OBJECTIVE: Recent study showed high chemokine CXC ligand 5 (CXCL5) is thought to be associated with insulin resistance in humans. However, evidence from large-scale populations about the relationship between serum CXCL5 level and metabolic phenotypes is scarce. Here we sought to evaluate serum CXCL5 distribution and its association with metabolic phenotypes among middle-aged and older Chinese. RESEARCH DESIGN AND METHODS: We evaluated serum CXCL5 in a cross-sectional sample of 3225 Chinese aged from 50 to 88 yr in a Shanghai downtown district by ELISA. Glucose, insulin, lipid profile, inflammatory marker, and adipokine were also measured.
RESULTS: The crude mean of serum CXCL5 concentrations were 1493.31 pg/ml for men and 2059.42 pg/ml for women (P<0.001), respectively. After multiple adjustment, the odds ratios were substantially higher for hypercholesterolemia (odds ratio 3.26, 95% confidence interval 2.36-4.51) in the highest CXCL5 quartile compared with those in the lowest quartile. These associations remained significant after further adjustment for body mass index, body fat, inflammatory marker, and adipokine. However, serum resistin CXCL5 was not associated with body mass index, percent body fat, fasting glucose, insulin levels, and homeostasis model assessment index-insulin resistance (r=0.01, 0.01, 0.01, 0.04, and 0.03, respectively; all P>0.05).
CONCLUSIONS: Elevated circulating CXCL5 concentrations were associated with higher risk of hypercholesterolemia in middle-aged and elderly Chinese independent of obesity, inflammation, adipokines, and other risk factors but not insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501684     DOI: 10.1210/jc.2009-2194

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties.

Authors:  Haiyang Zhang; Hongxiu Ning; Lia Banie; Guifang Wang; Guiting Lin; Tom F Lue; Ching-Shwun Lin
Journal:  Biochem Biophys Res Commun       Date:  2010-10-27       Impact factor: 3.575

2.  Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease.

Authors:  Zi Ye; Suijun Wang; Zhen Yang; Min He; Shuo Zhang; Weiwei Zhang; Jie Wen; Qin Li; Ying Huang; Xuanchun Wang; Bin Lu; Zhaoyun Zhang; Qing Su; Renming Hu
Journal:  Mol Biol Rep       Date:  2014-01-04       Impact factor: 2.316

3.  Mild hypercholesterolemia blunts the proinflammatory and prothrombotic effects of hypertension on the cerebral microcirculation.

Authors:  Stephen F Rodrigues; Shantel A Vital; D Neil Granger
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-02       Impact factor: 6.200

4.  Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes.

Authors:  Qin Li; Zhen Yang; Bin Lu; Jie Wen; Zi Ye; Lili Chen; Min He; Xiaoming Tao; Weiwei Zhang; Ying Huang; Zhaoyun Zhang; Shen Qu; Renming Hu
Journal:  Cardiovasc Diabetol       Date:  2011-08-04       Impact factor: 9.951

5.  Prevalence of non-alcoholic fatty liver disease and its relation to hypoadiponectinaemia in the middle-aged and elderly Chinese population.

Authors:  Zhen Yang; Xuanchun Wang; Jie Wen; Zi Ye; Qin Li; Min He; Bin Lu; Charlotte Ling; Songhua Wu; Renming Hu
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

6.  Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people.

Authors:  Ying Huang; Zhen Yang; Zi Ye; Qin Li; Jie Wen; Xiaoming Tao; Lili Chen; Min He; Xuanchun Wang; Bin Lu; Zhaoyun Zhang; Weiwei Zhang; Shen Qu; Renming Hu
Journal:  Cardiovasc Diabetol       Date:  2012-01-31       Impact factor: 9.951

7.  The Stanford Data Miner: a novel approach for integrating and exploring heterogeneous immunological data.

Authors:  Janet C Siebert; Wes Munsil; Yael Rosenberg-Hasson; Mark M Davis; Holden T Maecker
Journal:  J Transl Med       Date:  2012-03-28       Impact factor: 5.531

8.  Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes.

Authors:  Li Sheng; Wenjie Cao; Bingbing Cha; Zhaoping Chen; Fang Wang; Jun Liu
Journal:  Cardiovasc Diabetol       Date:  2013-01-23       Impact factor: 9.951

9.  CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults.

Authors:  Amber L Beitelshees; Christina L Aquilante; Hooman Allayee; Taimour Y Langaee; Gregory J Welder; Richard S Schofield; Issam Zineh
Journal:  Hum Genomics       Date:  2012-08-02       Impact factor: 4.639

10.  Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.

Authors:  Saranya Ravi; Robert N Schuck; Eleanor Hilliard; Craig R Lee; Xuming Dai; Kaitlin Lenhart; Monte S Willis; Brian C Jensen; George A Stouffer; Cam Patterson; Jonathan C Schisler
Journal:  Am J Pathol       Date:  2017-11-16       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.